Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.
REVOLUTION Medicines
19 followers
Halozyme Therapeutics
10 followers
Celldex Therapeutics
5 followers
Stemline Therapeutics
4 followers
Abeona Therapeutics
3 followers
ACROBiosystems
3 followers
Viridian Therapeutics
2 followers
RayzeBio
2 followers
Solid Biosciences
2 followers
Spero Therapeutics
2 followers
Cibus
5 followers
Cytek Biosciences
1 follower